Ming Wang
7 Papers
Ming Wang is an academic researcher. The author has contributed to research in topics: Medicine & Colorectal cancer. The author has an hindex of 2, co-authored 4 publications.
Chat about Author
Papers
PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer
Xu Wang,Rui Sun,Shixin Chan,Lei Meng,Yuanmin Xu,Xiaomin Zuo,Zhenglin Wang,Xianyu Hu,Qi Han,Longfei Dai,Tao Bai,Zhentao Yu,Ming Wang,Wenqi Yang,Huabing Zhang,Wei Xian Chen +15 more
TL;DR: The potential of PANoptosis-based molecular clustering and prognostic signatures for prediction of patient survival and tumor microenvironment (TME) in colon cancer is demonstrated.
A novel oxidative stress- and ferroptosis-related gene prognostic signature for distinguishing cold and hot tumors in colorectal cancer
Xu Wang,Yuanmin Xu,Longfei Dai,Zhen Yu,Ming Wang,Shixin Chan,Rui Sun,Qi Han,Jiajie Chen,Xiaomin Zuo,Zhenglin Wang,Xianyu Hu,Yang Yang,Hua Zhao,Kong-Wang Hu,Huabing Zhang,Wei Chen +16 more
TL;DR: Wang et al. as discussed by the authors developed an oxidative stress and ferroptosis-related gene (OFRG) prognostic signature to predict the prognosis and therapeutic response in patients with colorectal cancer.
Identification of cuproptosis-based molecular subtypes, construction of prognostic signature and characterization of immune landscape in colon cancer
Xu Wang,Xiaomin Zuo,Xianyu Hu,Yuyao Liu,Zhenglin Wang,Shixin Chan,Rui Sun,Qi Han,Zhentao Yu,Ming Wang,Huabing Zhang,Wei Chen +11 more
TL;DR: In this paper , the role of cuproptosis-related genes (CRGs) in the clinical outcomes and immune landscape of colon cancer remain unknown, and the authors performed bioinformatics analysis of the expression data of 13 CRGs identified from a previous study and clinical information of patients with colon cancer obtained from The Cancer Genome Atlas and Gene Expression Omnibus databases.
CBX2 Deletion Suppresses Growth and Metastasis of Colorectal Cancer by Mettl3-p38/ERK MAPK Signalling Pathway
Xucan Tu,Shixin Chan,Xu Wang,Zhenglin Wang,Zhentao Yu,Xiaomin Zuo,Qing Zhang,Jiajie Chen,Qi Han,Ming Wang,Hu Zhao,Huabing Zhang,Wei Chen +12 more
TL;DR: CBX2 deletion suppresses growth and metastasis of colorectal cancer by targeting the Mettl3-p38/ERK MAPK signaling pathway.
3
Identification of novel T cell proliferation patterns, potential biomarkers and therapeutic drugs in colorectal cancer
Xu Wang,Shixin Chan,Longfei Dai,Yuanmin Xu,Qi Yang,Ming Wang,Qi Han,Jiajie Chen,Xiaomin Zuo,Zhenglin Wang,Yang Yang,Hu Zhao,Guihong Zhang,Huabing Zhang,Wei Chen +14 more
TL;DR: T cell proliferation-based molecular subtypes and predictive signatures can be utilized to anticipate patient results, immunological landscape, and treatment response in CRC.